AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase
The deal is AstraZeneca's second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to shore up its rare…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cancer Drugs
Venus Remedies gets marketing approvals from Oman, Malaysia, Bosnia and Trinidad & Tobago
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Venus Remedies gets marketing approval for cancer drugs from Uzbekistan, Palestine
Venus Remedies is expected to launch these drugs in the two countries in the next financial year
Finland’s Orion to focus on cancer and pain drugs
The Helsinki-based firm said cancer diseases have long been one of its three core therapy areas
Existing cancer drugs to be trialled as new treatment for breast cancer
Two drugs that are already being used separately in the treatment of some prostate, renal and skin cancers, will now be tested in…
Merck KGaA signs deal with Artios Pharma for cancer drugs research
Artios will receive $30 million in up-front and near-term payments, plus double-digit option fees and up $860 million total…
Roche gets US FDA approval for Tecentriq combo to treat advanced melanoma
The approval is based on results from the Phase III IMspire150 study, in which the addition of Tecentriq to Cotellic and Zelboraf…
Anti-inflammatory and cancer drugs tested in UK as possible COVID-19 therapy
Izana Bioscience's Namilumab, a monoclonal antibody already in late-stage tests to treat rheumatoid arthritis and an inflammatory…
Merck receives FDA Fast Track Designation for Evofosfamide
It will help in treating patients living with advanced pancreatic cancer
Novartis completes series of transactions with GlaxoSmithKline
Acquires certain oncology products and pipeline compounds from GSK